Unless you are living under a rock, you know that cannabis legalization, for both medical and adult use purposes, is moving forward nation-by-nation across Europe and around the world. European medicinal sales doubled last year, and we can expect growth to continue rather aggressively as progress begets progress. Germany has been the leader on medical…
Germany’s medical cannabis program has grown by leaps and bounds and you don’t have to be too knowledgeable about Europe to know the influence that the German economy has on the region. The International Cannabis Business Conference (ICBC) has grown right along with Germany’s cannabis market, and the Berlin event has become the ICBC’s flagship with more…
The forces currently shaping the European cannabis map are intriguing this spring and from several directions. For the latest developments in Europe and across the globe, there will be no better place learn and network with those leading the way, than at the International Cannabis Business Conference in Zurich with Cannatrade. In the meantime, here…
The day after the third annual International Cannabis Business Conference (ICBC) in Berlin, as the crew packed up and headed on to Zurich, news about the German cultivation bid surfaced in the domestic media. Namely, that three bid finalists (Aurora, Aphria and Demecan, a start-up founded with Wayland) had been selected. This is unofficial “news”…
The first week of March this year was significant for British cannabis patients for one very big reason: the first medical cannabis clinic in the country opened in Manchester. Firsts are very important right now for both the British industry and patients, as are overall numbers in general. This is because, despite reform happening in…
Those who know anything about the history of the Dutch cannabis industry, know it is a vertical that has flourished in the grey areas and the loopholes of the law since its “modern” launch a couple of generations ago. However, for most of the last decade, the Dutch government has also struggled to find a…
While those in the Canadian cannabis market are certainly far ahead in obtaining full recreational acceptance for cannabis, and state markets in the U.S. are growing increasingly sophisticated, Germany has been and will continue to be one of the world’s most interesting cannabis markets for at least the next decade to come. Why? The Market…
According to a late January press release by the ever-tight lipped BfArM – the federal agency in charge of launching Germany’s medical cannabis cultivation program – the first harvest of medical cannabis is expected in the fourth quarter of 2020. Further, the award will not be announced before April 10 of this year, a topic…
Wayland Corporation announced a major victory in Germany last week. The company received GMP certification for its Ebersbach facility near Dresden, in eastern Germany. The timing of the certification is certainly favorable, coming just two months before the German cultivation bid (round 2) is supposed to be announced and, just like last time, presumably have…
There are clearly “banner years” for the modern age of cannabis reform that can be marked, by canna-historians, in different regions, states and countries. The turning of the century marked the beginning of constitutional protections for reasonable access to medicinal cannabis for approved patients (see Canada). In the second decade of the century, this watershed…
